JPWO2024242065A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2024242065A5
JPWO2024242065A5 JP2025515487A JP2025515487A JPWO2024242065A5 JP WO2024242065 A5 JPWO2024242065 A5 JP WO2024242065A5 JP 2025515487 A JP2025515487 A JP 2025515487A JP 2025515487 A JP2025515487 A JP 2025515487A JP WO2024242065 A5 JPWO2024242065 A5 JP WO2024242065A5
Authority
JP
Japan
Prior art keywords
nucleic acid
group
cationic
acid delivery
delivery structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025515487A
Other languages
English (en)
Japanese (ja)
Other versions
JP7725042B2 (ja
JPWO2024242065A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2024/018410 external-priority patent/WO2024242065A1/ja
Publication of JPWO2024242065A1 publication Critical patent/JPWO2024242065A1/ja
Publication of JPWO2024242065A5 publication Critical patent/JPWO2024242065A5/ja
Application granted granted Critical
Publication of JP7725042B2 publication Critical patent/JP7725042B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025515487A 2023-05-19 2024-05-17 造血器腫瘍治療用組成物、造血器腫瘍治療用医薬、及び造血器腫瘍における癌化細胞の増殖抑制用組成物 Active JP7725042B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023082728 2023-05-19
JP2023082728 2023-05-19
PCT/JP2024/018410 WO2024242065A1 (ja) 2023-05-19 2024-05-17 核酸送達用構造体の造血器腫瘍の治療への使用

Publications (3)

Publication Number Publication Date
JPWO2024242065A1 JPWO2024242065A1 (https=) 2024-11-28
JPWO2024242065A5 true JPWO2024242065A5 (https=) 2025-06-03
JP7725042B2 JP7725042B2 (ja) 2025-08-19

Family

ID=93589879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025515487A Active JP7725042B2 (ja) 2023-05-19 2024-05-17 造血器腫瘍治療用組成物、造血器腫瘍治療用医薬、及び造血器腫瘍における癌化細胞の増殖抑制用組成物

Country Status (5)

Country Link
EP (1) EP4714453A1 (https=)
JP (1) JP7725042B2 (https=)
CN (1) CN121175056A (https=)
AU (1) AU2024276929A1 (https=)
WO (1) WO2024242065A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10487103B2 (en) 2015-03-24 2019-11-26 Gifu University Oligonucleotide derivative, oligonucleotide construct using the same, and methods for producing them
WO2017179660A1 (ja) 2016-04-14 2017-10-19 国立大学法人岐阜大学 マイクロｒｎａ－１４３誘導体
US20240238325A1 (en) 2021-04-28 2024-07-18 Japan Science And Technology Agency Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same

Similar Documents

Publication Publication Date Title
US5596091A (en) Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
JP4012579B2 (ja) ２’−エーテル基を有するヌクレオシド及びオリゴヌクレオチド
EP0552766B1 (de) Oligonucleotidanaloga, deren Herstellung und Verwendung
JP3482209B2 (ja) オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデート：合成および化合物；ハイブリダイゼーションおよびヌクレアーゼ耐性特性
DE69403642T2 (de) 7-deazapurin modifizierte oligonukleotide
JP2022048248A (ja) 延長リピート病を処置するためのオリゴヌクレオチド
JP2021533804A5 (https=)
EP0839830B1 (en) Polyether nucleic acids
JP2022533722A5 (https=)
RU2740501C2 (ru) МОДИФИЦИРОВАННЫЕ ОЛИГОНУКЛЕОТИДЫ, АКТИВИРУЮЩИЕ РНКазу Н
JPH05505101A (ja) オリゴヌクレオチド療法における三重らせん形成
JPH11310593A (ja) 新規ペプチド核酸
EP1142902B1 (de) 3'-Derivatisierte Oligonucleotidanaloga mit nichtnucleotidischen Gruppierungen, deren Herstellung und Verwendung
CN116348150A (zh) 用于递送治疗剂的脂质缀合物
AU769619B2 (en) Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
JP6704196B2 (ja) オリゴヌクレオチド
CN118984717A (zh) Arnatar化合物和用于增强细胞摄取的方法
WO1996019240A1 (en) Oligonucleotide-dendrimer conjugates
JPWO2024242065A5 (https=)
EP0358657B1 (en) Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides)
US6017895A (en) Oligonucleotides possessing zwitterionic moieties
US9994604B2 (en) Pyrazolotriazolyl nucleoside analogues and oligonucleotides comprising them
CN118146277A (zh) 一种含有1,2,3-三氮唑结构的GalNAc化合物及其与寡核苷酸缀合方法
JP7725042B2 (ja) 造血器腫瘍治療用組成物、造血器腫瘍治療用医薬、及び造血器腫瘍における癌化細胞の増殖抑制用組成物
AU781297B2 (en) Chimeric DNA/RNA ribozymes containing propanediol